Start for free
Start for free
AP

ADAR1 Partners

Description

ADAR1 Partners operates as an investment firm.

Investor Profile

ADAR1 Partners has made 4 investments, with 1 in the past 12 months and 50% as lead.

Stage Focus

  • Post Ipo Equity (75%)
  • Series D (25%)

Country Focus

  • United States (75%)
  • Canada (25%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Internet
  • Marketplace
  • Outdoors
  • Peer To Peer
  • Medical Device
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ADAR1 Partners frequently co-invest with?

AC
AIGH Capital Management
North America, Maryland, United States, Baltimore
Co-Investments: 1
Nantahala Capital Management
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 3
Altos Ventures
Altos Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
CV
Convivialite Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Moore Strategic Ventures
Moore Strategic Ventures
North America, New York, United States, New York
Co-Investments: 1
MC
Monashee Capital Corp.
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
SiriusPoint
SiriusPoint
North America, Hamilton, Bermuda, Hamilton
Co-Investments: 1
iAngels
iAngels
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Greenspring Associates
Greenspring Associates
North America, Maryland, United States, Owings Mills
Co-Investments: 1
SC
Stonepine Capital Management
North America, Oregon, United States, Bend
Co-Investments: 2

What are some of recent deals done by ADAR1 Partners?

Grace Therapeutics

Laval, Quebec, Canada

Grace Therapeutics is an emerging biopharmaceutical company.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityFeb 10, 2025
Amount Raised: $10,467,142
Kiora Pharmaceuticals

Salt Lake City, Utah, United States

Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityJan 31, 2024
Amount Raised: $15,000,000
Cellectar Biosciences

Madison, Wisconsin, United States

Cellectar Biosciences is a pharmaceutical research company specializing in cancer drugs.

BiotechnologyMedical DeviceTherapeutics
Post Ipo EquitySep 5, 2023
Amount Raised: $103,000,000
Outdoorsy

Austin, Texas, United States

Outdoorsy is a marketplace platform that connects RV owners with other campers.

InternetMarketplaceOutdoorsPeer to Peer
Series DJun 24, 2021
Amount Raised: $90,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator